Cognitive Deficits and Altered Cholinergic Innervation in Young Adult Mice Carrying a Parkinson's Disease LRRK2-G2019S Knockin Mutation
Ayan HusseiniD, Alexander TielemansiD, Mark G. BaxteriD, Deanna L. BensoniD, George W. HuntleyiD
Abstract
Impaired executive function is a common and debilitating non-motor symptom of idiopathic and hereditary Parkinsons disease (PD), but there is little understanding of the underlying pathophysiological mechanisms and circuits. The G2019S mutation in the kinase domain of leucine-rich repeat kinase 2 (LRRK2) greatly increases risk for late-onset PD, and non-manifesting LRRK2-G2019S carriers also exhibit early and significant cognitive impairment. Here, we subjected young adult mice carrying a Lrrk2-G2019S knockin mutation to touchscreen-based operant tasks that measure attention, goal-directed learning and cognitive flexibility, all of which rely on prefrontal-striatal connectivity and are strongly modulated by cholinergic innervation. In a visuospatial attention task, mutant mice exhibited significantly more omissions and longer response latencies than controls that could not be attributed to deficits in motivation, visual sensory perception per se or locomotion, thereby suggesting impairment in divided attention and slower information processing speed. Pretreating mice with the acetylcholinesterase inhibitor donepezil normalized both higher omission rates and longer reward latencies in the mutants, but did not affect any performance metric in controls. Strikingly, cholinergic fiber density in mPFC and dorsomedial striatum was significantly sparser in mutants than in controls, while further behavioral interrogation of the mutants revealed significant impairments in action-outcome associations but preserved cognitive flexibility. These data suggest that the G2019S mutation impacts cholinergic innervation and impairs corticostriatal network function in young adulthood that may contribute to early PD-associated cognitive deficits. STATEMENT OF SIGNIFICANCEThe LRRK2-G2019S mutation causes hereditary Parkinsons disease and is found in some idiopathic cases. Early cognitive impairment is a common symptom of hereditary and idiopathic PD, yet there is little mechanistic understanding of such impairment. Here, we tested young adult Lrrk2-G2019S knockin mice in a series of touchscreen-based visuospatial tasks. We found that mutants exhibited significant deficits in attention and goal-directed learning, and had significantly slower information processing speed. Treatment with an acetylcholinesterase inhibitor reversed some of these behavioral deficits, while anatomical analyses showed significantly sparser cholinergic innervation of brain structures important for executive function. These findings suggest the G2019S mutation alters cholinergic signaling in young adulthood, and thus may contribute to early PD-associated impairment in several cognitive domains.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 19
- FWCI
- 2.37
- Field percentile
- top 10%
- Organism
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Pathogenic LRRK2 R1441C mutation is associated with striatal alterations
Harry S. Xenias, Chuyu Chen, … Loukia Parisiadou·Communications BiologyPeer-reviewed·Nov 10, 2022
- Pathogenic LRRK2 causes age-dependent and region-specific deficits in ciliation, innervation and viability of cholinergic neurons
Besma Brahmia, Yahaira Naaldijk, … Sabine Hilfiker·bioRxiv·Jul 16, 2024
- Combined knockout of Lrrk2 and Rab29 does not result in behavioral abnormalities in vivo
M. C. Mazza, V. Nguyen, … M. R. Cookson·Journal of Parkinson's DiseasePeer-reviewed·Apr 13, 2021
- Parkinson's-linked LRRK2-G2019S derails AMPAR trafficking, mobility and composition in striatum with cell-type and subunit specificity
Swati Gupta, Alexander Tielemans, … Deanna L. Benson·Proceedings of the National Academy of SciencesPeer-reviewed·Jul 5, 2024
- LRRK2 kinase inhibition reverses G2019S mutation-dependent effects on tau pathology spread
Noah Lubben, Julia K. Brynildsen, … Michael X. Henderson·Translational NeurodegenerationPeer-reviewed·Mar 4, 2024
- Dopaminergic Neurodegeneration Induced by Parkinson's Disease-Linked G2019S LRRK2 is Dependent on Kinase and GTPase Activity
An Phu Tran Nguyen, Elpida Tsika, … Darren J. Moore·Proceedings of the National Academy of SciencesPeer-reviewed·Jul 6, 2020